[{"id":"1f8bf35c-c5e0-487a-987a-3fa6416c7152","acronym":"","url":"https://clinicaltrials.gov/study/NCT05967416","created_at":"2023-08-01T16:10:21.784Z","updated_at":"2024-07-02T16:35:26.181Z","phase":"Phase 1","brief_title":"Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma","source_id_and_acronym":"NCT05967416","lead_sponsor":"SIRPant Immunotherapeutics, Inc.","biomarkers":" SIRPA","pipe":"","alterations":" ","tags":["SIRPA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SIRPant-M (RB-1355)"],"overall_status":"Recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 12/01/2023","start_date":" 12/01/2023","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2023-12-14"}]